M. Khair ElZarrad - Concepedia

Author

M. Khair ElZarrad

United States Food and Drug Administration ORCID

Also Known As

Hugh Harvey, Ludwig C. Hinske, M Khair ElZarrad, M Khair Elzarrad, M. Elzarrad, M. Khair ElZarrad, Mohammed K. Elzarrad, Mohammed Khair Elzarrad, Tala H. Fakhouri

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research National Cancer Institute National Institutes of Health Cancer Genetics (United States)

About

M. Khair ElZarrad is an author at United States Food and Drug Administration specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	274
2	Business	1	1	27
3	Engineering	1	1	27
4	Health Sciences	1	1	25
5	Natural Sciences	1	1	20

M. Khair ElZarrad

Publications

782

Citations

H-Index

Page 1

	Year	Citations
GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrier Mike Cullen, M. Khair ElZarrad, Steven Seaman, Proceedings of the National Academy of Sciences	2011	213
Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice M. Khair ElZarrad, Partha Mukhopadhyay, Nishant Mohan, PLoS ONE Cardiac MuscleHeart FailureImmunologyCardiovascular ToxicityHumanized Monoclonal Antibody	2013	135
Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes Nishant Mohan, Yi Shen, Yukinori Endo, Molecular Cancer Therapeutics	2016	127
Landscape Analysis of the Application of Artificial Intelligence and Machine Learning in Regulatory Submissions for Drug Development From 2016 to 2021 Qi Liu, Ruihao Huang, Julie Hsieh, Clinical Pharmacology & Therapeutics	2022	76
Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative Karim A. Calis, Patrick Archdeacon, Raymond P. Bain, Clinical Trials	2017	57
Application of Machine Learning in Drug Development and Regulation: Current Status and Future Potential Qi Liu, Hao‐Jie Zhu, Chao Liu, Clinical Pharmacology & Therapeutics Drug IntelligenceMachine LearningPredictive ToxicologyDrug DesignMedicine	2020	48
The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton Mi Yang, Amit Chaudhary, Steven Seaman, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research MedicineActin CytoskeletonCancer Cell BiologyCell-matrix InteractionCell Migration	2010	44
Advancing an agile regulatory ecosystem to respond to the rapid development of innovative technologies M. Khair ElZarrad, Aaron Lee, Rose Purcell, Clinical and Translational Science Artificial IntelligenceEngineeringSoftware EngineeringRapid DevelopmentClinical System	2022	27
The US Food and Drug Administration's Real‐World Evidence Framework: A Commitment for Engagement and Transparency on Real‐World Evidence M. Khair ElZarrad, Jacqueline Corrigan‐Curay Clinical Pharmacology & Therapeutics Public PolicyHealth PolicyReal‐world Evidence FrameworkDrug PolicyReal-world Evidence	2019	25
Insulin activation of vacuolar protein sorting 34 mediates localized phosphatidylinositol 3-phosphate production at lamellipodia and activation of mTOR/S6K1 Dianne S. Hirsch, Yi Shen, Milos Dokmanovic, Cellular Signalling Protein FunctionSignal TransductionMolecular PhysiologyBiochemistryInsulin Activation	2014	20

Page 1